SCHEMBL4302235

SCHEMBL4302235

CCOC(=O)c1cn(C2CC2)c2c(OC(F)F)c(OS(=O)(=O)C(F)(F)F)c(F)cc2c1=O

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.49
KCNH2 Q12809 5/20 0.44
GSK3B P49841 2/20 0.41
TOP2A P11388 4/20 0.40
TOP2B Q02880 4/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.40
PRKD3 O94806 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
OPRM1 P35372 1/20 0.40
CLK2 P49760 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 1/20 0.39
STAT3 P40763 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4302223 0.91 ADRB2 (0.51) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL7126309 0.89 ADRB2 (0.57) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL115392 0.89 ADRB2 (0.55) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL1984659 0.85 ADRB2 (0.58) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL117416 0.84 ADRB2 (0.47) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL4297280 0.83 ADRB2 (0.54) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL12835804 0.81 ADRB2 (0.44) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL4296349 0.79 ADRB2 (0.47) ADRB2KCNH2TOP2ATOP2BKDM4E
SCHEMBL10412626 0.79 TOP2A (0.47) ADRB2KCNH2GSK3BTOP2ATOP2B
SCHEMBL116913 0.79 ADRB2 (0.57) ADRB2KCNH2GSK3BTOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS NQO2, QARS1, NQO1 ADRB2 3156/4885KCNH2 3433/4885GSK3B 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.